Re: Genomic Classifier Identifies Men with Adverse Pathology after Radical Prostatectomy Who Benefit from Adjuvant Radiation Therapy

European Urology

Volumn 68, Issue 2, 2015, Pages 337-338

  Isbarn, Hendrik ^a   Giannarini, Gianluca ^b  

^a Regio Klinik Wedel   (Germany)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ASSESSMENT OF HUMANS; BIOCHEMICAL RECURRENCE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; GENOMIC CLASSIFIER SCORE; GLEASON SCORE; HIGH RISK POPULATION; HUMAN; MALE; METASTASIS; METASTASIS FREE SURVIVAL; NOTE; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; ADJUVANT THERAPY; GENETICS; PROCEDURES; PROSTATIC NEOPLASMS;

HUMANS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 84937395588     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.03.014     Document Type: Note

References (3)

1. N. Erho, A. Crisan, I.A. Vergara, and et al. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy PLoS One 8 2013 e66855
2. M.R. Cooperberg, J.F. Hilton, and P.R. Carroll The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy Cancer 117 2011 5039 5046
3. A.J. Stephenson, P.T. Scardino, J.A. Eastham, and et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005 7012